Active Pharmaceutical Ingredient (Generic)

DACOMITINIB

🩺 ANTINEOPLASTICS 💊 1 Marketed Brands
Clinical Profile:

*Non-small cell lung cancer with activating epidermal growth factor receptor (EGFR) mutations (specialist use only):* Adult: 45 mg once daily, for dose adjustments, treatment interruption or discontinuation; consult product literature.

Marketed Brands Containing DACOMITINIB (1) Compare Brand Prices
Brand Name Manufacturer / Company Available Pack Sizes & Price Action
DACOVIZ 🏢 PFIZER
Tab FCT 45 mg 10: Rs.42677.59
Tab FCT 15 mg 10: Rs.31430.40
Tab FCT 30 mg 10: Rs.42677.59
View Details →